Tacrolimus imme rel oral 1mg
Products billed under this code include Prograf, Tacolimus, Tacrolimus.
Payment limit per 1 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under J7507
From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Prograf | Astellas Pharma US, Inc. | 00469-0607-73 | 50 | $8.10 |
| Prograf | Astellas Pharma US, Inc. | 00469-0617-73 | 100 | $16.20 |
| Prograf | Astellas Pharma US, Inc. | 00469-0657-73 | 500 | $81.00 |
| Tacolimus | Quallent Pharmaceuticals | 82009-0164-01 | 50 | $8.10 |
| Tacrolimus | Mylan Pharmaceuticals Inc. | 00378-2045-01 | 50 | $8.10 |
| Tacrolimus | Mylan Pharmaceuticals Inc. | 00378-2046-01 | 100 | $16.20 |
| Tacrolimus | Mylan Pharmaceuticals Inc. | 00378-2047-01 | 500 | $81.00 |
| Tacrolimus | Sandoz Inc. | 00781-2102-01 | 50 | $8.10 |
| Tacrolimus | Sandoz Inc. | 00781-2103-01 | 100 | $16.20 |
| Tacrolimus | Sandoz Inc. | 00781-2104-01 | 500 | $81.00 |
Show all 40 products
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Tacrolimus | Major Pharmaceuticals | 00904-7097-61 | 100 | $16.20 |
| Tacrolimus | Northstar RxLLC | 16714-0098-01 | 50 | $8.10 |
| Tacrolimus | Northstar RxLLC | 16714-0099-01 | 100 | $16.20 |
| Tacrolimus | Northstar RxLLC | 16714-0100-01 | 500 | $81.00 |
| Tacrolimus | Accord Healthcare Inc | 16729-0041-01 | 50 | $8.10 |
| Tacrolimus | Accord Healthcare Inc | 16729-0042-01 | 100 | $16.20 |
| Tacrolimus | Accord Healthcare Inc | 16729-0043-01 | 500 | $81.00 |
| Tacrolimus | A-S Medication Solutions | 50090-5581-00 | 90 | $14.58 |
| Tacrolimus | A-S Medication Solutions | 50090-5596-00 | 90 | $14.58 |
| Tacrolimus | Dr. Reddy's Laboratories Inc. | 55111-0525-01 | 50 | $8.10 |
| Tacrolimus | Dr. Reddy's Laboratories Inc. | 55111-0526-01 | 100 | $16.20 |
| Tacrolimus | Dr. Reddy's Laboratories Inc. | 55111-0527-01 | 500 | $81.00 |
| Tacrolimus | Strides Pharma Science Limited | 64380-0720-06 | 50 | $8.10 |
| Tacrolimus | Strides Pharma Science Limited | 64380-0721-06 | 100 | $16.20 |
| Tacrolimus | Strides Pharma Science Limited | 64380-0722-06 | 500 | $81.00 |
| Tacrolimus | Ascend Laboratories, LLC | 67877-0278-01 | 50 | $8.10 |
| Tacrolimus | Ascend Laboratories, LLC | 67877-0279-01 | 100 | $16.20 |
| Tacrolimus | Ascend Laboratories, LLC | 67877-0280-01 | 500 | $81.00 |
| Tacrolimus | American Health Packaging | 68084-0449-01 | 50 | $8.10 |
| Tacrolimus | American Health Packaging | 68084-0450-01 | 100 | $16.20 |
| Tacrolimus | American Health Packaging | 68084-0451-01 | 500 | $81.00 |
| Tacrolimus | Glenmark Pharmaceuticals Inc., USA | 68462-0685-01 | 50 | $8.10 |
| Tacrolimus | Glenmark Pharmaceuticals Inc., USA | 68462-0686-01 | 100 | $16.20 |
| Tacrolimus | Glenmark Pharmaceuticals Inc., USA | 68462-0687-01 | 500 | $81.00 |
| Tacrolimus | Biocon Pharma Inc | 70377-0014-11 | 50 | $8.10 |
| Tacrolimus | Biocon Pharma Inc | 70377-0015-11 | 100 | $16.20 |
| Tacrolimus | Biocon Pharma Inc | 70377-0016-11 | 500 | $81.00 |
| Tacrolimus | Civica, Inc. | 72572-0760-01 | 50 | $8.10 |
| Tacrolimus | Civica, Inc. | 72572-0761-01 | 100 | $16.20 |
| Tacrolimus | Quallent Pharmaceuticals | 82009-0054-01 | 100 | $16.20 |
Every quarter
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $0.162 | −$0.038 | 1 MG | Tacrolimus imme rel oral 1mg | v1, posted September 17, 2026 |
| 3Q26 | $0.20 | −$0.03 | 1 MG | Tacrolimus imme rel oral 1mg | v1, posted September 15, 2026 |
| 2Q26 | $0.23 | +$0.033 | 1 MG | Tacrolimus imme rel oral 1mg | v1, posted September 15, 2026 |
| 1Q26 | $0.197 | +$0.028 | 1 MG | Tacrolimus imme rel oral 1mg | v1, posted September 15, 2026 |
| 4Q25 | $0.169 | +$0.015 | 1 MG | Tacrolimus imme rel oral 1mg | v1, posted September 8, 2026 |
| 3Q25 | $0.154 | −$0.04 | 1 MG | Tacrolimus imme rel oral 1mg | v1, posted March 10, 2026 |
| 2Q25 | $0.194 | +$0.018 | 1 MG | Tacrolimus imme rel oral 1mg | v1, posted March 10, 2026 |
| 1Q25 | $0.176 | −$0.079 | 1 MG | Tacrolimus imme rel oral 1mg | v1, posted December 19, 2025 |
| 4Q24 | $0.255 | +$0.02 | 1 MG | Tacrolimus imme rel oral 1mg | v1, posted June 11, 2025 |
| 3Q24 | $0.235 | −$0.036 | 1 MG | Tacrolimus imme rel oral 1mg | v1, posted June 11, 2025 |
| 2Q24 | $0.271 | +$0.035 | 1 MG | Tacrolimus imme rel oral 1mg | v1, posted March 11, 2025 |
| 1Q24 | $0.236 | −$0.064 | 1 MG | Tacrolimus imme rel oral 1mg | v1, posted December 19, 2024 |
| 4Q23 | $0.30 | +$0.013 | 1 MG | Tacrolimus imme rel oral 1mg | v1, posted October 10, 2024 |
| 3Q23 | $0.287 | −$0.063 | 1 MG | Tacrolimus imme rel oral 1mg | v1, posted June 5, 2024 |
| 2Q23 | $0.35 | +$0.05 | 1 MG | Tacrolimus imme rel oral 1mg | v1, posted February 23, 2024 |
| 1Q23 | $0.30 | −$0.008 | 1 MG | Tacrolimus imme rel oral 1mg | v1, posted December 6, 2023 |
| 4Q22 | $0.308 | −$0.067 | 1 MG | Tacrolimus imme rel oral 1mg | v1, posted June 22, 2023 |
| 3Q22 | $0.375 | −$0.075 | 1 MG | Tacrolimus imme rel oral 1mg | v1, posted June 9, 2023 |
| 2Q22 | $0.45 | −$0.069 | 1 MG | Tacrolimus imme rel oral 1mg | v1, posted December 14, 2022 |
| 1Q22 | $0.519 | −$0.029 | 1 MG | Tacrolimus imme rel oral 1mg | v1, posted June 8, 2022 |
| 4Q21 | $0.548 | +$0.028 | 1 MG | Tacrolimus imme rel oral 1mg | v1, posted June 2, 2022 |
| 3Q21 | $0.52 | −$0.048 | 1 MG | Tacrolimus imme rel oral 1mg | v1, posted June 2, 2022 |
| 2Q21 | $0.568 | −$0.001 | 1 MG | Tacrolimus imme rel oral 1mg | v1, posted March 1, 2022 |
| 1Q21 | $0.569 | – | 1 MG | Tacrolimus imme rel oral 1mg | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.
CMS source files
- 4Q26: 2026-09-17_october-2026-medicare-part-b-payment-limit-files-final.zipposted September 17, 2026
- 4Q26: 2026-09-17_october-2026-ndc-hcpcs-crosswalk-final.zipposted September 17, 2026
- 3Q26: 2026-09-15_july-2026-medicare-part-b-payment-limit-files.zipposted September 15, 2026
- 2Q26: 2026-09-15_april-2026-medicare-part-b-payment-limit-files-final-file.zipposted September 15, 2026
- 1Q26: 2026-09-15_january-2026-medicare-part-b-payment-limit-files.zipposted September 15, 2026
- 4Q25: 2026-09-08_october-2025-asp-pricing-final-file.zipposted September 8, 2026
- 3Q25: 2026-03-10_july-2025-asp-pricing-file.zipposted March 10, 2026
- 2Q25: 2026-03-10_april-2025-asp-pricing-file.zipposted March 10, 2026
- 1Q25: 2025-12-19_january-2025-asp-pricing-file-03-11-25-final-file.zipposted December 19, 2025
- 4Q24: 2025-06-11_october-2024-asp-pricing-file.zipposted June 11, 2025
- 3Q24: 2025-06-11_july-2024-asp-pricing-file.zipposted June 11, 2025
- 2Q24: 2025-03-11_april-2024-asp-pricing-file.zipposted March 11, 2025
- 1Q24: 2024-12-19_january-2024-asp-pricing-file.zipposted December 19, 2024
- 4Q23: 2024-10-10_october-2023-asp-pricing-file.zipposted October 10, 2024
- 3Q23: 2024-06-05_july-2023-asp-pricing-file.zipposted June 5, 2024
- 2Q23: 2024-02-23_april-2023-asp-pricing-file.zipposted February 23, 2024
- 1Q23: 2023-12-06_january-2023-asp-pricing-file.zipposted December 6, 2023
- 4Q22: 2023-06-22_october-2022-asp-pricing-file.zipposted June 22, 2023
- 3Q22: 2023-06-09_july-2022-asp-pricing-file.zipposted June 9, 2023
- 2Q22: 2022-12-14_april-2022-asp-pricing-file.zipposted December 14, 2022
- 1Q22: 2022-06-08_january-2022-asp-pricing-file.zipposted June 8, 2022
- 4Q21: 2022-06-02_october-2021-asp-pricing-file.zipposted June 2, 2022
- 3Q21: 2022-06-02_july-2021-asp-pricing-file.zipposted June 2, 2022
- 2Q21: 2022-03-01_april-2021-asp-pricing-file.zipposted March 1, 2022
- 1Q21: 2021-12-10_january-2021-asp-pricing-file.zipposted December 10, 2021